Northwestern Mutual Wealth Management
PDSB icon

Northwestern Mutual Wealth Management’s PDS Biotechnology PDSB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-257
Closed -$306 – 3920
2025
Q1 		$306 Buy
+257
New +$366 ﹤0.01% 3421
2024
Q3 		– Sell
-28
Closed -$82 – 3782
2024
Q2 		$82 Buy
+28
New +$90 ﹤0.01% 3400
2022
Q1 		– Sell
-43
Closed – – 3325
2021
Q4 		$0 Buy
+43
New +$463 ﹤0.01% 3281

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northwestern Mutual Wealth Management's PDSB Position: Q2 2025 in Review

Northwestern Mutual Wealth Management sold out of PDS Biotechnology (PDSB) in Q2 2025, closing a stake of 257 shares — an estimated $306 sold.

Northwestern Mutual Wealth Management first reported a position in PDSB in Q4 2021 and held it in 3 quarters. The position peaked at $306 in Q1 2025. 55 funds tracked by Wall St. Rank hold PDSB as of Q2 2025.

  • Northwestern Mutual Wealth Management reported no remaining PDS Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 257 PDS Biotechnology shares in Q2 2025, an estimated $306.
  • Northwestern Mutual Wealth Management first reported a position in PDS Biotechnology in Q4 2021 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's PDS Biotechnology position peaked at $306 in Q1 2025.
  • 55 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.